Reston, VA
United States
- Reston, VA
- 01/12/2022
- Series B
- $47,000,000
PROOF stands for the Pro Rata Opportunity Fund. We invest strategic capital alongside select early stage VC firms, to maximize upside in their best performing companies.
Venture capital firms investing in early stage companies typically negotiate ‘pro-rata investment rights,’ allowing them to maintain ownership in subsequent rounds of funding as they grow. Since early stage VCs invest across a broad swath of portfolio companies, over time, they inevitably run out of capital to maintain their pro-rata ownership in their best performing companies. When pro-rata is surrendered, board seats and the right to invest in future rounds are at stake.
Through our investments, we allow our network partner VCs to maintain their influence on the board, preserve their position in the cap table and optimize returns in companies experiencing meteoric growth.
- Industry Venture Capital and Private Equity Principals
- Website https://www.proof.vc/
- LinkedIn https://www.linkedin.com/company/proof.vc/
Related People
Thanasis DelistathisInvestor
United States -
Bethesda, Maryland
Growth investor. Generalist. Like: Marketplaces, Disruptive business models, New frontier markets.
Parhelia Biosciences | Undisclosed Amount | (Oct 18, 2023)
Cloover | $7,388,000 | (Oct 18, 2023)
Hallmark Health Care Solutions | Undisclosed Amount | (Oct 18, 2023)
Prove | $40,000,000 | (Oct 18, 2023)
Reality Defender | $15,000,000 | (Oct 18, 2023)
Yardstik | $12,000,000 | (Oct 18, 2023)
Nucleus RadioPharma | $56,000,000 | (Oct 18, 2023)
Society Brands | $25,000,000 | (Oct 18, 2023)
Nova Credit | $45,000,000 | (Oct 18, 2023)
Anonybit | $3,000,000 | (Oct 18, 2023)
Zelus Analytics | Undisclosed Amount | (Oct 18, 2023)
Scorability | $11,000,000 | (Oct 18, 2023)